Modeling and Estimation of Kinetic Parameters and Replicative Fitness of HIV-1 from Flow-Cytometry-Based Growth Competition Experiments

Growth competition assays have been developed to quantify the relative fitness of HIV-1 mutants. In this article, we develop mathematical models to describe viral/cellular dynamic interactions in the assay system from which the competitive fitness indices or parameters are defined. In our previous HIV-viral fitness experiments, the concentration of uninfected target cells was assumed to be constant (Wu et al. 2006). But this may not be true in some experiments. In addition, dual infection may frequently occur in viral fitness experiments and may not be ignorable. Here, we relax these two assumptions and extend our earlier viral fitness model (Wu et al. 2006). The resulting models then become nonlinear ODE systems for which closed-form solutions are not achievable. In the new model, the viral relative fitness is a function of time since it depends on the target cell concentration. First, we studied the structure identifiability of the nonlinear ODE models. The identifiability analysis showed that all parameters in the proposed models are identifiable from the flow-cytometry-based experimental data that we collected. We then employed a global optimization approach (the differential evolution algorithm) to directly estimate the kinetic parameters as well as the relative fitness index in the nonlinear ODE models using nonlinear least square regression based on the experimental data. Practical identifiability was investigated via Monte Carlo simulations.

[1]  G. Bocharov,et al.  Recombination: Multiply infected spleen cells in HIV patients , 2002, Nature.

[2]  Alan S Perelson,et al.  HIV dynamics with multiple infections of target cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Julio R. Banga,et al.  Solving nonconvex climate control problems: pitfalls and algorithm performances , 2004, Appl. Soft Comput..

[4]  Wei-Shau Hu,et al.  Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Claudio Cobelli,et al.  Global identifiability of nonlinear models of biological systems , 2001, IEEE Transactions on Biomedical Engineering.

[6]  Rainer Storn,et al.  Differential Evolution – A Simple and Efficient Heuristic for global Optimization over Continuous Spaces , 1997, J. Glob. Optim..

[7]  Xiaohua Xia,et al.  Identifiability of nonlinear systems with application to HIV/AIDS models , 2003, IEEE Trans. Autom. Control..

[8]  J. Holland,et al.  Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses , 1991, Journal of virology.

[9]  B. Korber,et al.  HIV sequence compendium 2002 , 2002 .

[10]  T. H. I. Jaakola,et al.  Optimization by direct search and systematic reduction of the size of search region , 1973 .

[11]  R. Storn,et al.  Differential Evolution: A Practical Approach to Global Optimization (Natural Computing Series) , 2005 .

[12]  P. Englezos,et al.  Comparison of the Luus−Jaakola Optimization and Gauss−Newton Methods for Parameter Estimation in Ordinary Differential Equation Models , 2006 .

[13]  Hulin Wu,et al.  Deterministic And Stochastic Models Of Aids Epidemics And Hiv Infections With Intervention , 2005 .

[14]  C. Boucher,et al.  Implications of antiretroviral resistance on viral fitness , 2001, Current opinion in infectious diseases.

[15]  Alan S. Perelson,et al.  Modeling and Estimation of Replication Fitness of Human Immunodeficiency Virus Type 1 In Vitro Experiments by Using a Growth Competition Assay , 2006, Journal of Virology.

[16]  C. Fraser HIV recombination: what is the impact on antiretroviral therapy? , 2005, Journal of The Royal Society Interface.

[17]  C. Dykes,et al.  Relative replication fitness of efavirenz-resistant mutants of HIV-1: correlation with frequency during clinical therapy and evidence of compensation for the reduced fitness of K103N + L100I by the nucleoside resistance mutation L74V. , 2006, Virology.

[18]  E. Arts,et al.  A Dual Infection/Competition Assay Shows a Correlation between Ex Vivo Human Immunodeficiency Virus Type 1 Fitness and Disease Progression , 2000, Journal of Virology.

[19]  A S Perelson,et al.  Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase , 1996, Journal of virology.

[20]  Sebastian Bonhoeffer,et al.  Procedures for reliable estimation of viral fitness from time-series data , 2002, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[21]  Xiaohua Xia,et al.  IDENTIFIABILITY OF HIV/AIDS MODELS , 2005 .

[22]  Anthony C. Davison,et al.  Bootstrap Methods and Their Application , 1998 .

[23]  R de Boer,et al.  Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215 , 1997, Journal of virology.

[24]  Wilco Keulen,et al.  Estimating Relative Fitness in Viral Competition Experiments , 2000, Journal of Virology.

[25]  G. Shaw,et al.  Dynamics of HIV-1 recombination in its natural target cells , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[26]  E. Arts,et al.  HIV-1 Fitness : Implications for Drug Resistance , Disease Progression , and Global Epidemic Evolution , 2002 .

[27]  J. Shao,et al.  The jackknife and bootstrap , 1996 .

[28]  B. Clotet,et al.  Relative replication fitness of multi-nucleoside analogue-resistant HIV-1 strains bearing a dipeptide insertion in the fingers subdomain of the reverse transcriptase and mutations at codons 67 and 215. , 2004, Virology.

[29]  C. Cobelli,et al.  Global identifiability of linear compartmental models-a computer algebra algorithm , 1998, IEEE Transactions on Biomedical Engineering.

[30]  Haihong Zhu,et al.  Parameter Identifiability and Estimation of HIV/AIDS Dynamic Models , 2008, Bulletin of mathematical biology.

[31]  D. Lamarre,et al.  Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors , 1997, Journal of virology.

[32]  Jianbo Chen,et al.  Mechanisms of Nonrandom Human Immunodeficiency Virus Type 1 Infection and Double Infection: Preference in Virus Entry Is Important but Is Not the Sole Factor , 2005, Journal of Virology.

[33]  Jianbo Chen,et al.  Nonrandom HIV-1 infection and double infection via direct and cell-mediated pathways. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[34]  P. Harrigan,et al.  Relative Replicative Fitness of Zidovudine-Resistant Human Immunodeficiency Virus Type 1 Isolates In Vitro , 1998, Journal of Virology.

[35]  Alan S. Perelson,et al.  Multiplicity of Human Immunodeficiency Virus Infections in Lymphoid Tissue , 2004, Journal of Virology.

[36]  G. Seber,et al.  Nonlinear Regression: Seber/Nonlinear Regression , 2005 .

[37]  Hulin Wu,et al.  Evaluation of a Multiple-Cycle, Recombinant Virus, Growth Competition Assay That Uses Flow Cytometry To Measure Replication Efficiency of Human Immunodeficiency Virus Type 1 in Cell Culture , 2006, Journal of Clinical Microbiology.

[38]  J. Martinez-Picado,et al.  Replicative Fitness of Protease Inhibitor-Resistant Mutants of Human Immunodeficiency Virus Type 1 , 1999, Journal of Virology.

[39]  N. Kalogerakis,et al.  Applied parameter estimation for chemical engineers , 2000 .

[40]  Lennart Ljung,et al.  On global identifiability for arbitrary model parametrizations , 1994, Autom..

[41]  Stephen J. Wright,et al.  Numerical Optimization , 2018, Fundamental Statistical Inference.

[42]  Elijah Paintsil,et al.  Competitive Fitness of Nevirapine-Resistant Human Immunodeficiency Virus Type 1 Mutants , 2004, Journal of Virology.

[43]  X. Xia ESTIMATION OF HIV/AIDS PARAMETERS , 2002 .

[44]  Julio R. Banga,et al.  Novel metaheuristic for parameter estimation in nonlinear dynamic biological systems , 2006, BMC Bioinformatics.